References
- Anane R, Creppy EE. (2001). Lipid peroxidation as pathway of aluminium cytotoxicity in human skin fi broblast cultures: prevention by superoxide dismutase+catalase and vitamins E and C. Hum Exp Toxicol 20: 477-481.
- Armstrong RA, Winsper SJ, Blair JA. (1996). Aluminium and Alzheimer’s disease: review of possible pathogenic mechanisms. Dementia 7 (1): 1-9.
- Baur JA, Sinclair DA. (2006). Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5(6): 493-506.
- Bimla Nehru, Priya Anand. (2005). Oxidative damage following chronic aluminium exp- osure in adult and pup rat brains. Journal of Trace Elements in Medicine and Biology 19 203-208.
- Blaylock RL. (2012). Aluminium induced immunoexcitotoxicity in neurodevelopmental and neurodegenerative disorders. Current Inorganic Chemistry Vol. 2 (1): 1-8.
- Dua R, Gill KD. (2001). Aluminium phospide exposure: implications on rat brain lipid Peroxidation and antioxidant defence system. Pharmacol Toxicol 89 (6): 315-319.
- Frankel, EN, Waterhouse AL, Kinsella JE. (1993). Inhibition of human LDL oxidation by resveratrol. Lancet 341(8852):1103-4.
- Fremont L. (2000). Biological eff ects of resveratrol. Life Sci 66(8): 663-673.
- Granados-Soto V. (2003). Pleiotropic eff ects of resveratrol. Drug News Perspect 16(5): 299-307.
- Isokawa M, Levesque MF. (1991). Increased NMDA responses and dendritic degeneration in human epileptic hippocampal neurons in slices. Neurosci Lett 132 (2): 212-216.
- Kawahara M. (2005). Eff ects of aluminum on the nervous system and its possible link with neurodegenerative diseases. J of Alzheimers Dis 8 (2): 171-182.
- Kelsey A. Potter, Amy C. Buck, Wade K. Self, Megan E. Callan, Smrithi Sunil, Jeff rey R. Capadona. (2013). The eff ect of resveratrol on neurodegeneration and blood brain barrier stability surrounding intracortical microemectrodes. Biomaterials 34: 7001-7015
- Kono Y. (1978). Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys 186(1): 189-195.
- Luck H. (1971). Methods of enzymatic analysis. New York: Academic Press 885-93.
- Luna LG. (1968). Manual of Histological Staining Methods of the Armed Forces institute of Pathology. 3rd Edition. McGraw-Hill, NY 36-37.
- Mundy WR, Freudenrich TM, Kodavanti PR. (1997). Aluminum potentiates glutamate-induced calcium accumulation and iron-induced oxygen free radical formation in primary neuronal cultures. Molecular and Chemical Neuropathology 32(1-3): 41-57.
- Neri LC, Hewitt D. (1991). Aluminium, Alzheimer’s disease, and drinking water. Lancet 338(8763): 390.
- Schroeder JC, Tolbert PE, Eisen EA, Monson RR, Hallock MF, Smith TJ, Woskie R, Hammond SK, Milton DK. (1997). Mortality studies of machining fl uid exposure in the automobile industry. IV: A case-control study of lung cancer. Am J Ind Med 31 (5):525-33.
- Tadolini B, Juliano C, Piu L, Franconi F, Cabrini L. (2000). Resveratrol inhibition of lipid peroxidation. Free Radic Res 33 (1):105-14.
- Varner JA, Jensen KF, Horvath W, Isaacson RL. (1998). Chronic administration of aluminum-fl uoride or sodium-fl uoride to rats in drinking water: alterations in neuronal and cerebrovascular integrity. Brain Res 784(1-2): 284-98.
- Walton JR. (1996). Amyloid, aluminium and the aetiology of Alzheimer’s disease. Med J Aust 164 (6): 382-383.
- Wills ED. (1966). Mechanisms of lipid peroxide formation in animal tissues. Biochem J 99(3): 667-676.